Pfizer Inc (NYSE:PFE) sells its PAPPL to Pfizer Animal Health India Ltd (PAHIL) for Rs 471.60 crore

  on Dec 10,2012 Posted in Business News ,Finance
 
Share |
We're on   

On Friday, Pfizer Inc (NYSE:PFE) declared that it has closed the sale of its subsidiary, PAPPL, to Pfizer Animal Health India Ltd (PAHIL), which is owned by US-based Pfizer Inc, for Rs 471.60 crore.

The company stated that all the transactions have completed and the company received the consideration amount of Rs 471.60 crore.

It was stated by the Pfizer Ltd that the development is part of a universal internal re-organization taken up by its parent, Pfizer Inc, in July 2011. Under this program, it was evaluating strategic substitutes for its global animal health business.

PFE’s animal health business basically deals in the large animal health and poultry market segments and also includes rendering of marketing services.

Pfizer Inc. (NYSE:PFE) total value after the recent close was $188.19 billion and the enterprise value according to Yahoo data was $204.55 billion. The previous 12 month price to sales ratio was 3.03. The company showed 15.69% as a profit margin in the last twelve months and an operating margin at 20.12%. Return on equity was 11.05% for the last twelve months. Return on assets was 5.03%.

Taking a look at some competitors, the total value of Merck & Co., Inc. (NYSE:MRK) in the stock market was $135.68 billion and the takeover value of the company was $136.80 billion. The last twelve month price to sales ratio for the company was 2.83. It had a 14.41% profit margin in the last twelve months and an operating margin at 18.79%. Return on assets was 6.48%.

The total value of Novartis AG (ADR) (NYSE:NVS) after the latest trading session was $150.72 billion and their enterprise value was $144.51 billion. The prior 52 week price to sales ratio was 2.63. The company recorded a profit margin of 15.21% for the prior 12 months and had an operating margin of 18.00%. Return on equity for this stock was 12.96% while return on assets appeared at 7.21%.

Sanofi SA (ADR) (NYSE:SNY) market capitalization after the most recent trading session was $122.08 billion and the enterprise value was $136.34 billion. Price to sales ratio for the prior 52 weeks was 2.59.

 

 

 



 

Leave a Reply